Company Filing History:
Years Active: 2002
Title: Martin Schiestl: Innovator in Nucleic Acid Technology
Introduction
Martin Schiestl is a notable inventor based in Kufstein, Austria. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid molecules.
Latest Patents
Schiestl holds a patent for a nucleic acid molecule encoding a cephalosporin acetylesterase. This invention relates to a nucleic acid molecule that codes for the cephalosporin acetylesterase from ATCC 6633 (DSM 11909). The patent also includes vectors and host cells that comprise such a nucleic acid molecule, a process for the recombinant preparation of cephalosporin acetylesterase, and a method for preparing 3-deacetylcephalosporin compounds. He has 1 patent to his name.
Career Highlights
Martin Schiestl is associated with Biochemie Gesellschaft M.b.h., where he applies his expertise in biotechnology. His work has contributed to advancements in the understanding and application of nucleic acids in various biotechnological processes.
Collaborations
Schiestl has collaborated with notable colleagues, including Franz Knauseder and Kurt Schörgendorfer. Their combined efforts have furthered research and development in their respective fields.
Conclusion
Martin Schiestl is a distinguished inventor whose work in nucleic acid technology has made a significant impact in biotechnology. His contributions continue to influence the field and inspire future innovations.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.